Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06854302 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Angina After PCI: a Systems Medicine Study

Study acronym: CorMicA-PCI
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
Angina may persist or recur in patients treated by coronary angioplasty. The angioplasty involves a balloon treatment to open a blocked heart blood vessel and usually a stent (thin metal tube) is placed. Stents do not always improve symptoms and may make symptoms worse. Sometimes a drug-eluting-balloon is used instead of a stent. This balloon coats the inside of the blood vessel to prevent re-narrowing. Research is needed to clarify the causes of ongoing angina and its impact on patients and the NHS, and to identify which patients will or will not benefit from a stent (hence avoiding over-treatment in the future). We plan a 5-year UK-wide multicenter study involving up to 600 patients with angina undergoing coronary angioplasty (with or without a stent). They will initially have a heart MRI scan. We will assess what might influence the recurrence of angina in the year after the angioplasty procedure. We will measure small blood vessel function in the heart and the amount of plaque persisting after PCI. Patients who report angina after coronary angioplasty usually have a second invasive angiogram. Instead, we will invite patients to have a heart MRI scan allowing us to also assess whether this scan might be more useful than a repeat angiogram in guiding clinical care. We will collaborate with life scientists, mathematicians, statisticians, and health economists to better understand causes and health economic implications of angina arising after coronary angioplasty procedures.
Trial Details
NCT Number NCT06854302
Lead Sponsor NHS National Waiting Times Centre Board
Collaborators: Robertson Centre for Biostatistics - University of Glasgow, British Heart Foundation, Abbott Medical Devices, CoreAalst BV, National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)
Angina (Stable), Ischemic Heart Disease (IHD)
Related terms Angina Pectoris, Angina, Stable, Coronary Artery Disease, Microvascular Angina, Myocardial Ischemia
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov